Table 5.
Results of stem cell transplantation in MDS patients with MF = 0/1 or MF = 2/3 (n = 141)
| MF = 0/1) (n = 121) | MF = 2/3 (n = 20) | P | |
|---|---|---|---|
| Cumulative incidence of neutrophil reconstruction at day + 30 | 98.3% | 95.0% | 0.107 |
| Cumulative incidence of platelet reconstruction at day + 30 | 87.6% | 80.0% | 0.303 |
| Median days to neutrophil reconstruction(> 0.5 × 109/L) (range) | 12(7–34) | 14(10–45) | 0.005 |
| Median days to platelet reconstruction(> 20X109/L) (range) | 14(8–68) | 18(8–65) | 0.045 |
| Acute GVHD grade II–IV | 45(37.2%) | 6(30%) | 0.535 |
| Chronic GVHD | 67(55.4%) | 10(50%) | 0.655 |
| 2 year cumulative incidence of relapse | 12.0% | 16.8% | 0.910 |
| 2 year non-replase mortality | 26.0% | 21.7% | 0.441 |